Allogeneic transplantation outcomes in chronic myeloid leukemia in the era of tyrosine kinase inhibitors. Wernicke GJ, Enrico AI, Cattaneo M, Bendek Del Prete GE, et al. Int J Hematol 2026 Sep 23. doi: 10.1007/s12185-026-04281.

Read + Share

Amedeo Smart

Independent Medical Education

Wernicke GJ, Enrico AI, Cattaneo M, Bendek Del Prete GE, et al. Allogeneic transplantation outcomes in chronic myeloid leukemia in the era of tyrosine kinase inhibitors. Int J Hematol 2026 Sep 23. doi: 10.1007/s12185-026-04281.
PMID: 42776396